| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.36 | 0.04 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |